Dickinson Andrew D 4

What Happened

• Andrew D. Dickinson, Chief Financial Officer of Gilead Sciences (GILD), was credited with 44,867 shares as an award (performance-based) on Feb 3, 2026. To satisfy tax withholding related to the award, 24,802 shares were transferred/disposed at $143.28 each, a value of $3,553,631. The award is reported as an A (award/acquisition) and the withholding as F (tax withholding/payment).

Key Details

• Transaction dates: Feb 3, 2026 (award and tax-withholding reported); Form 4 filed Feb 5, 2026 (appears timely).
• Award: 44,867 shares @ $0.00 (acquired; performance-vesting certified).
• Tax withholding: 24,802 shares @ $143.28 (disposed) = $3,553,631.
• Net shares from this transaction (gross award minus shares withheld): 20,065 shares (44,867 − 24,802), subject to the caveat below.
• Shares owned after the transaction: not specified in the provided filing.
• Footnote: These shares represent specific tranches of performance share awards granted March 10, 2023 and March 10, 2024. Performance targets were certified, but shares certified from the March 10, 2024 grant will not be issued until the required continuing service vesting is met.

Context

• This was an award (not an open-market purchase), and the sale/transfer reported was a tax-withholding event common with equity awards; such withholding is routine and does not necessarily signal insider sentiment. The filing indicates performance-based vesting was certified, but some tranches remain subject to continued service before actual issuance.